Baillie Gifford & Co
NVCR icon

Baillie Gifford & Co’s NovoCure NVCR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$20.1M Sell
1,128,652
-8,328
-0.7% -$148K 0.02% 189
2025
Q1
$20.3M Sell
1,136,980
-24,330
-2% -$434K 0.02% 179
2024
Q4
$34.6M Sell
1,161,310
-498,004
-30% -$14.8M 0.03% 161
2024
Q3
$25.9M Sell
1,659,314
-28,207
-2% -$441K 0.02% 169
2024
Q2
$28.9M Sell
1,687,521
-302,854
-15% -$5.19M 0.02% 163
2024
Q1
$31.1M Sell
1,990,375
-2,849,766
-59% -$44.5M 0.02% 170
2023
Q4
$72.3M Sell
4,840,141
-1,974,073
-29% -$29.5M 0.06% 139
2023
Q3
$110M Sell
6,814,214
-1,876,250
-22% -$30.3M 0.1% 120
2023
Q2
$361M Buy
8,690,464
+86,963
+1% +$3.61M 0.31% 76
2023
Q1
$517M Sell
8,603,501
-260,341
-3% -$15.7M 0.47% 55
2022
Q4
$650M Sell
8,863,842
-50,349
-0.6% -$3.69M 0.68% 39
2022
Q3
$677M Sell
8,914,191
-202,039
-2% -$15.4M 0.7% 40
2022
Q2
$634M Sell
9,116,230
-224,615
-2% -$15.6M 0.65% 42
2022
Q1
$774M Sell
9,340,845
-274,323
-3% -$22.7M 0.54% 49
2021
Q4
$722M Buy
9,615,168
+245,463
+3% +$18.4M 0.4% 67
2021
Q3
$1.09B Buy
9,369,705
+68,624
+0.7% +$7.97M 0.57% 47
2021
Q2
$2.06B Buy
9,301,081
+437,149
+5% +$97M 1.01% 25
2021
Q1
$1.17B Buy
8,863,932
+602,857
+7% +$79.7M 0.66% 40
2020
Q4
$1.43B Buy
8,261,075
+136,430
+2% +$23.6M 0.8% 32
2020
Q3
$904M Buy
8,124,645
+220,925
+3% +$24.6M 0.62% 37
2020
Q2
$469M Buy
7,903,720
+167,102
+2% +$9.91M 0.36% 53
2020
Q1
$521M Sell
7,736,618
-272,364
-3% -$18.3M 0.56% 36
2019
Q4
$675M Sell
8,008,982
-644,636
-7% -$54.3M 0.65% 32
2019
Q3
$647M Sell
8,653,618
-175,831
-2% -$13.1M 0.74% 32
2019
Q2
$558M Buy
8,829,449
+789,924
+10% +$49.9M 0.59% 41
2019
Q1
$387M Buy
8,039,525
+3,541,001
+79% +$171M 0.42% 58
2018
Q4
$151M Buy
4,498,524
+971,424
+28% +$32.5M 0.2% 82
2018
Q3
$185M Buy
3,527,100
+433,705
+14% +$22.7M 0.2% 81
2018
Q2
$96.8M Buy
3,093,395
+343,756
+13% +$10.8M 0.1% 90
2018
Q1
$59.9M Buy
2,749,639
+2,145,522
+355% +$46.8M 0.07% 100
2017
Q4
$12.2M Buy
+604,117
New +$12.2M 0.02% 160